CollPlant Biotechnologies
CLGN
CLGN
18 hedge funds and large institutions have $8.55M invested in CollPlant Biotechnologies in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
31% less capital invested
Capital invested by funds: $12.5M → $8.55M (-$3.92M)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Holders
18
Holding in Top 10
1
Calls
–
Puts
–
Top Sellers
1 | -$35.3K | |
2 | -$23.5K | |
3 | -$5.89K | |
4 |
UBS Group
Zurich,
Switzerland
|
-$4.78K |
5 |
First Manhattan
New York
|
-$816 |